The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1447-1459

  Huang, Fang Ping ^a   Feng, Gui Jie ^a   Lindop, George ^a   Stott, David I ^a   Liew, Foo Y ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; GLOMERULONEPHRITIS; IMMUNOPATHOGENESIS; MALE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULONEPHRITIS; INTERFERON TYPE II; INTERLEUKIN-12; KIDNEY; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; NITRIC OXIDE; PERITONEUM; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES;

EID: 0029880442     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1447     Document Type: Article

References (47)

1. Cohen, P.L., and R.A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferarive disease. Annu. Rev. Immunol. 9:243-269.
2. Andrew, B.S., R.A. Eisenberg, A.N. Theofilopoulos, S. Izui, C.B. Wilson, P.J. McConahey, E.D. Murphy, J.B. Roths, and F.J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198-1215.
3. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
4. Watson, M.L., J.K. Rao, G.K. Gilkeson, P. Ruiz, E.M. Eicher, D.M. Pisetsky, A. Matsuzawa, J.M. Rochelle, and M.F. Seldin. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease modifying loci. J. Exp. Med. 176:1645-1656.
5. G-monomethyl-L-arginine. J. Exp. Med. 179:651-660.
6. Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-142.
7. Nathan, C.F., and J B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
8. Liew, F.Y., and F.E.G. Cox. 1991. Non-specific defence mechanism: the role of nitric oxide. Immunol. Today. A17-21.
9. Marletta, M.A. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:12231-12234.
10. Bredt, D.S., and S.H. Snyder. 1994. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:175-195.
11. Nathan, C., and Q.-w. Xie. 1994. Nitric oxide synthase: roles, tolls, and control. Cell. 78:915-918.
12. Vladutiu, A.O. 1995. Role of nitric oxide in autoimmunity. Clin. Immunol. Immunopathol. 76:1-11.
13. Liew, F.Y. 1995. Regulation of lymphocyte functions by nitric oxide. Curr. Opin Immunol. 7:396-399.
14. Palmer, R.M.J., D.S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond.). 333:664-666.
15. Kwon, N.S., C.F. Nathan, C. Gilker, O. Griffith, D. Mathews, and D.J. Stuehr. 1990. L-citrulline production from L-arginine by macrophage nitric oxide synthase; the ureido oxygen derives from dioxygen. J. Biol. Chem. 265:13442-13445.
16. Leone, A.M., R.M.J. Palmer, R.G. Knowles, P.L. Francis, D.S. Ashton, and S. Moncada. 1991. Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J. Biol. Chem. 266:23790-23795.
17. Nathan, C., and Q.-W. Xie 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
18. Theofilopoulos, A.N. 1992. Munne models of lupus. In Systemic Lupus Erythematosus. 2nd ed., Section II. R.G. Lahita, editor. Churchhill Livingstone, Inc., New York. 121-194.
19. Umland, S., R. Lee, M. Howard, and C. Martens. 1989. Expression of lymphokine genes in splenic lymphocytes of autoimmune mice. Mol. Immunol. 26:649-656.
20. Hutchings, P.R., G Cambridge, J.P. Tite, A. Meager, and A. Cooke. 1989. The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays. J. Immunol. Methods. 120:1-8.
21. Palmer, R.M.J., A.G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond.). 327:524-526.
22. Green, L.C., D. Wagner, J. Glogowski, P.L. Skipper, J.J. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
23. Luzuy, S., J. Merino, H. Engers, S. Izui, and P.-H. Lumbert. 1986. Autoimmunity after induction of neonatal tolerence to alloantigens: role of B cell chimaerism and F1 donor B cell activation. J. Immunol. 136:4420-4426.
24. Podlaski, F.J., V.B. Nanduri, J.D. Hulmes, Y.E. Pan, W. Levin, W. Danho, R. Chizzonite, M.K. Gately, and A.S. Stern. 1992. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294:230-237.
25. Trinchieri, G. Biology of natural killer cells. 1989. Adv Immunol. 47:187-376.
26. Rook, G.A.W., P.M. Lydyard, and J.L. Stanford. 1993. A reappraisal of the evidence that rheumatoid arthritis and several other idiopathic diseases are slow bacterial infections. Ann. Rheum. Dis. 52:S30-S38.
27. Taurog, J.D., J.A. Richardson, J.T. Croft, W.A. Simmons, M. Zhou, J.L. Fernandezsueiro, E. Balish, and R.E. Hammer. 1994. The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med 180:2359-2364.
28. D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg et al. 1992. Production of natüral killer cells stimulatory factor (IL-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
29. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of Interferon γ production by natural killer cell stimulatory factor: characterisation of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
30. Tripp, C.S., S.E. Wolf, and E.R. Unanue. 1993. Interleukin-12 and tumour necrosis fector α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin-10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA. 90:3725-3729.
31. Gazzinelli, R.T., S. Hieny, T.A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin-12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad. Sci. USA. 90:6115-6119.
32. + T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
33. + T cells to enhance priming for interferon-γ production and diminishes interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
34. Manetti, R., P. Parronchi, M.G. Guidizi, M.P. Piccinni, E. Maggi, G. Tnnchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin-12) induces T-helper type 1 (Th1)-specific immune response and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1199-1204.
35. Afonso, L.C.C., T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (Wash. DC). 263:235-237.
36. Liew, F.Y., and C.A. O'Donnell. 1993. Immunology of Leishmaniasis. Adv. Parasitol. 32:161-259.
37. Reiner, S.L., and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151-177.
38. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M.K. Gately, and L. Adorini. 1995. Interleukin-12 administration induces T-helper type-1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
39. Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-386.
40. Germann, T., J. Szeliga, H. Hess, S. Storkel, F.J. Podlaski, M.K. Gately, E. Schmitt, and E. Rude. 1995. Administration of interleukin-12 in combination with type-II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA. 92:4823-4827.
41. Corriea, P., J.S. Cameron, J.D. Lian, J. Hicks, C.S. Ogg, D.G. Williams, C. Chantier, and D.G. Haycock. 1985. Why do patients with lupus nephritis die? Br. Med. J. 290:126-131.
42. Brumfit, W., and A. Percival. 1964. Pathogenesis and laboratory diagnosis of non-tuberculous urinary tract infection. J. Clin. Pathol. 17:482-491.
43. Gutierrez-Ramos, J.C., J.L. Andreu, Y. Revilla, E. Vinuela, and C. Martinez-A. 1990. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature (Lond.). 346:271-274.
44. Huang, F.-P., and D.I. Stott. 1993. Restoration of an early, progressive defect in responsiveness to T-cell activation in lupus mice by exogenous IL-2. Autoimmunity. 15:19-29.
45. Pelton, B.K., and A.M. Denman. 1982. Defective B-cell function in systemic lupus erythematosus. Clin. Exp. Immunol. 48:513-518.
46. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90:1756-1760.
47. Kobayashi, S., T Hirano, M. Kakinuma, and T. Uede. 1993. Transcriptional repression and differential splicing of Fas messenger-RNA by early transposon (ETN) insertion in autoimmune lpr mice. Biochem. Biophy. Res. Commun. 191:617-624.